GLP-1 weight-loss drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications, a new study finds.
We bring you the latest updates from Healthcare in europe through a simple and fast subscription.
We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.
Unsubscribe at any time without hassle.
Healthcare in europe's title: Healthcare business news, trends & developments • healthcare-in-europe.com